ProstaLund AB (publ) (PLUN.ST)

SEK 0.22

(-3.86%)

Market Cap (In SEK)

32.47 Million

Revenue (In SEK)

22.2 Million

Net Income (In SEK)

-17.01 Million

Avg. Volume

152.74 Thousand

Currency
SEK
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.17-1.9
PE
-
EPS
-
Beta Value
0.554
ISIN
SE0002372318
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Mr. Anders Kristensson
Employee Count
-
Website
https://www.prostalund.se
Ipo Date
2013-10-25
Details
ProstaLund AB (publ) develops and sells urological devices for the treatment of patients with benign prostatic hyperplasia (BPH) in Sweden and internationally. The company also offers CoreTherm, a heat treatment of BPH; and Gepan instill for the treatment of chronic bladder inflammation. Its products are used in hospitals and clinics. The company was founded in 1991 and is based in Lund, Sweden. ProstaLund AB (publ) is a subsidiary of Farstorps Gard Forvaltnings AB.